Glucose-mediated induction of TGF-β1 and MCP-1 in mesothelial cells in vitro is osmolality and polyol pathway dependent

Kidney International

Volumn 63, Issue 4, 2003, Pages 1404-1416

  Wong, Teresa Y H ^a   Phillips, Aled O ^a   Witowski, Janusz ^a   Topley, Nicholas ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Glucose; Human peritoneal mesothelial cell; MCP 1; Osmolality; Peritoneal membrane function; Polyol pathway; TGF 1

Indexed keywords

ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; GLUCOSE; LACTATE SODIUM; MANNITOL; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; POLYOL; PYRUVATE SODIUM; SORBINIL; SORBITOL; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL ACTIVATION; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; MESOTHELIUM CELL; OSMOLALITY; PERITONEUM; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN SECRETION; REGULATORY MECHANISM;

EID: 0037378448     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00883.x     Document Type: Article

References (70)

1. HEIMBÜRGER O, WANIEWSKI J, WERYNSKI A, et al: Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int 38:495-506, 1990
2. STRUIJK DG, KREDIET RT, KOOMEN GC, et al: Functional characteristics of the peritoneal membrane in long-term continuous ambulatory peritoneal dialysis. Nephron 59:213-220, 1991
3. SLATER ND, COPE GH, RAFTERY AT: Mesothelial hyperplasia in response to peritoneal dialysis fluid: A morphometric study in the rat. Nephron 58:466-471, 1991
4. HONDA K, NITTA K, HORITA H, et al: Morphological changes in the peritoneal vasculature of patients on CAPD with ultrafiltration failure. Nephron 72:171-176, 1996
5. HONDA K, NITTA K, HORITA S, et al: Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration. Nephrol Dial Transplant 14:1541-1549, 1999
6. MATEIJSEN MA, VAN DER WAL AC, HENDRIKS PM, et al: Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int 19:517-525, 1999
7. WILLIAMS JD, CRAIG KJ, TOPLEY N, et al: Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 13:470-479, 2002
8. DEVUYST O, TOPLEY N, WILLIAMS JD: Morphological and functional changes in the dialysed peritoneal cavity: impact of more biocompatible solutions. Nephrol Dial Transplant 17:12-15, 2002
9. TOPLEY N: Membrane longevity in peritoneal dialysis: Impact of infection and bio-incompatible solutions. Adv Ren Replace Ther 5:179-184, 1998
10. TOPLEY N, WILLIAMS JD: The role of the peritoneal membrane in the control of inflammation in the peritoneal cavity. Kidney Int 46:S71-S78, 1994
11. TOPLEY N, LIBEREK T, DAVENPORT A, et al: Activation of inflammation and leukocyte recruitment into the peritoneal cavity. Kidney Int (Suppl 56):S17-S21, 1996
12. KUMANO K, SCHILLER B, HJELLE JT, et al: Effect of osmotic solutes on fibronectin mRNA expression in rat peritoneal mesothelial cells. Blood Purif 14:165-169, 1996
13. KANG DH, HONG YS, LIM HJ, et al: High glucose solution and spent dialysate stimulate the synthesis of transforming growth factor-beta1 of human peritoneal mesothelial cells: Effect of cytokine costimulation. Perit Dial Int 19:221-230, 1999
14. ROUGIER J-P, MOULLIER P, PIEDAGNEL R, et al: Hyperosmolality supresses but TGF-β1 increases MMP9 in human peritoneal mesothelial cells. Kidney Int 51:337-347, 1997
15. NISHIMURA C, HOTTA Y, GUI T, et al: The level of erythrocyte aldose reductase is associated with the severity of diabetic retinopathy. Diabetes Res Clin Pract 37:173-177, 1997
16. ROBISON WG, JR, KADOR PF, AKAGI Y, et al: Prevention of basement membrane thickening in retinal capillaries by a novel inhibitor of aldose reductase, tolrestat. Diabetes 35:295-299, 1986
17. MORRISEY K, STEADMAN R, WILLIAMS JD, et al: Renal proximal tubular cell fibronectin accumulation in response to glucose is polyol pathway dependent. Kidney Int 55:160-167, 1999
18. BLEYER AJ, FUMO P, SNIPES ER, et al: Polyol pathway mediates high glucose-induced collagen synthesis in proximal tubule. Kidney Int 45:659-666, 1994
19. COWLEY BD, JR, FERRARIS JD, CARPER D, et al: In vivo osmoregulation of aldose reductase mRNA, protein, and sorbitol in renal medulla. Am J Physiol 258:F154-F161, 1990
20. OHTAKA M, TAWATA M, HOSAKA Y, et al: Glucose modulation of aldose reductase mRNA expression and its activity in cultured calf pulmonary artery endothelial cells. Diabetologia 35:730-734, 1992
21. GRUNEWALD RW, WAGNER M, SCHUBERT I, et al: Rat renal expression of mRNA coding for aldose reductase and sorbitol dehydrogenase and its osmotic regulation in inner medullary collecting duct cells. Cell Physiol Biochem 8:293-303, 1998
22. TILTON RG, BAIER LD, HARLOW JE, et al: Diabetes-induced glomerular dysfunction: Links to a more reduced cytosolic ratio of NADH/NAD+. Kidney Int 41:778-788, 1992
23. BRUNKHORST R, MAHIOUT A: Pyruvate neutralizes peritoneal dialysate cytotoxicity: Maintained integrity and proliferation of cultured human mesothelial cells. Kidney Int 48:177-181, 1995
24. DAVIES SJ, BRYAN J, PHILLIPS L, et al: Longitudinal changes in peritoneal kinetics: The effects of Peritoneal dialysis and peritonitis. Nephrol Dial Transplant 11:498-506, 1996
25. TEKSTRA J, VISSER CE, TUK CW, et al: Identification of the major chemokines that regulate cell influxes in peritoneal dialysis patients. J Am Soc Nephrol 7:2379-2384, 1996
26. LI FK, DAVENPORT A, ROBSON RL, et al: Leukocyte migration across human peritoneal mesothelial cells is dependent on directed chemokine secretion and ICAM-1 expression. Kidney Int 54:2170-2183, 1998
27. WITOWSKI J, JORRES A, COLES GA, et al: Superinduction of IL-6 synthesis in human peritoneal mesothelial cells is related to the induction and stabilization of IL-6 mRNA. Kidney Int 50:1212-1223, 1996
28. TOPLEY N, JORRES A, LUTTMANN W, et al: Human peritoneal mesothelial cells synthesize interleukin-6: Induction by IL-1 beta and TNF alpha. Kidney Int 43:226-233, 1993
29. TOPLEY N, KAUR D, PETERSEN MM, et al: Bio-compatibility of bicarbonate-buffered peritoneal dialysis fluids: Influence on mesothelial cell and neutrophil function. Kidney Int 49:1447-1456, 1996
30. O'BRYAN JP, FRYE RA, COGSWELL PC, et al: axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. Mol Cell Biol 11:5016-5031, 1991
31. BOHREN KM, BULLOCK B, WERMUTH B, et al: The aldo-keto reductase superfamily. cDNAs and deduced amino acid sequences of human aldehyde and aldose reductases. J Biol Chem 264:9547-9551, 1989
32. LEE FK, CHEUNG MC, CHUNG S: The human sorbitol dehydrogenase gene: cDNA cloning, sequence determination, and mapping by fluorescence in situ hybridization. Genomics 21:354-358, 1994
33. DERYNCK R, JARRETT JA, CHEN EY, et al: Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells. Nature 316:701-705, 1985
34. YOSHIMURA T, YUHKI N, MOORE SK, et al: Human monocyte chemoattractant protein-1 (MCP-1). Full length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett 244:487-493, 1989
35. FUCHS E, KIM KH, HANUKOGLU I, et al: The evolution and complexity of the genes encoding the cytoskeletal proteins of human epidermal cells. Curr Probl Dermatol 11:27-44, 1983
36. TOPLEY N: The host's initial response to peritoneal infection: The pivotal role of the mesothelial cell. Perit Dial Int 15:116-117, 1995
37. MACKENZIE RK, JONES S, MOSELEY A, et al: In vivo exposure to bicarbonate/lactate- and bicarbonate-buffered peritoneal dialysis fluids improves ex vivo peritoneal macrophage function. Am J Kidney Dis 35:112-121, 2000
38. JONES S, HOLMES CJ, KREDIET RT, et al: Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels. Kidney Int 59:1529-1538, 2001
39. CAPPELLI G, BANDIANI G, CANCARINI GC, et al: Low concentrations of glucose degradation products in peritoneal dialysis fluids and their impact on biocompatibility parameters: prospective crossover study with a three-compartment bag. Adv Perit Dial 15:238-242, 1999
40. RIPPE B, SIMONSEN O, HEIMBURGER O, et al: Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products. Kidney Int 59:348-357, 2001
41. ROSENBERG ME: Peritoneal dialysis: diabetes of the peritoneal cavity. J Lab Clin Med 134:103-104, 1999
42. BREBOROWICZ A, RODELA H, OREOPOULOS DG: Toxicity of osmotic solutes on human mesothelial cells in vitro. Kidney Int 41:1280-1285, 1992
43. SHOSTAK A, WAJSBROT V, GOTLOIB L: High glucose accelerates the life cycle of the in vivo exposed mesothelium. Kidney Int 58:2044-2052, 2000
44. ITO T, YORIOKA N, YAMAMOTO M, et al: Effect of glucose on intercellular junctions of cultured human peritoneal mesothelial cells. J Am Soc Nephrol 11:1969-1979, 2000
45. HA H, YU MR, LEE HB: High glucose-induced PKC activation mediates TGF-beta 1 and fibronectin synthesis by peritoneal mesothelial cells. Kidney Int 59:463-470, 2001
46. 2 synthesis in human peritoneal mesothelial cells: Role of hyperosmolarity. J Am Soc Nephrol 9:2005-2012, 1998
47. SITTER T, MANDL-WEBER S, WORNLE M, et al: D-glucose increases the synthesis of tissue-type plasminogen activator (t-PA) in human peritoneal mesothelial cells. Thromb Haemost 82:1171-1176, 1999
48. WILLIAMSON JR, CHANG K, FRANGOS M, et al: Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42:801-813, 1993
49. 2 activation. Metabolism 46:41-47, 1997
50. RUDERMAN NB, WILLIAMSON JR, BROWNLEE M: Glucose and diabetic vascular disease. FASEB J 6:2905-2914, 1992
51. PHILLIPS AO, TOPLEY N, STEADMAN R, et al: Induction of TGF-beta 1 synthesis in D-glucose primed human proximal tubular cells by IL-1 beta and TNF alpha. Kidney Int 50:1546-1554, 1996
52. YANG WS, KIM BS, LEE SK, et al: Interleukin-1 beta stimulates the production of extracellular matrix in cultured human peritoneal mesothelial cells. Perit Dial Int 19:211-220, 1999
53. ISHII H, TADA H, ISOGAI S: An aldose reductase inhibitor prevents glucose-induced increase in transforming growth factor-beta and protein kinase C activity in cultured mesangial cells. Diabetologia 41:362-364, 1998
54. CRAVEN PA, DERUBERTIS FR: Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. Possible mediation by glucose. J Clin Invest 83:1667-1675, 1989
55. KAPOR-DREZGIC J, ZHOU X, BABAZONO T, et al: Effect of high glucose on mesangial cell protein kinase C-delta and -epsilon is polyol pathway-dependent. J Am Soc Nephrol 10:1193-1203, 1999
56. ZHOU X, LI C, DLUGOSZ J, et al: Mesangial cell actin disassembly in high glucose mediated by protein kinase C and the polyol pathway. Kidney Int 51:1797-1808, 1997
57. DERYLO B, BABAZONO T, GLOGOWSKI E, et al: High glucose-induced mesangial cell altered contractility: Role of the polyol pathway. Diabetologia 41:507-515, 1998
58. NISHIZUKA Y: The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 308:693-698, 1984
59. HASLINGER B, MANDL-WEBER S, SELLMAYER A, et al: Effect of high glucose concentration on the synthesis of monocyte chemoattractant protein-1 in human peritoneal mesothelial cells: Involvement of protein kinase C. Nephron 87:346-351, 2001
60. HORIO M, YAMAUCHI A, MATSUOKA Y, et al: Effect of hypertonic stress on amino acid levels and system A activity in rat peritoneal mesothelial cells. Perit Dial Int 19:124-130, 1999
61. MATSUOKA Y, YAMAUCHI A, NAKANISHI T, et al: Response to hypertonicity in mesothelial cells: role of Na+/myo- inositol co-transporter. Nephrol Dial Transplant 14:1217-1223, 1999
62. BURGER-KENTISCHER A, MULLER E, MARZ J, et al: Hypertonicity-induced accumulation of organic osmolytes in papillary interstitial cells. Kidney Int 55:1417-1425, 1999
63. SHAPIRO L. DINARELLO CA: Osmotic regulation of cytokine synthesis in vitro. Proc Natl Acad Sci 92:12230-12234, 1995
64. GALCHEVA-GARGOVA Z, DERIJARD B, WU IH, et al: An osmosensing signal transduction pathway in mammalian cells. Science 265:806-808, 1994
65. TOPLEY N, ALOBAIDI HM, DAVIES M, et al: The effect of dialysate on peritoneal phagocyte oxidative metabolism. Kidney Int 34:404-411, 1988
66. LIBEREK T, TOPLEY N, JORRES A, et al: Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH. Nephron 65:260-265, 1993
67. DOUVDEVANI A, RAPOPORT J, KONFORTY A, et al: Intracellular acidification mediates the inhibitory effect of peritoneal dialysate on peritoneal macrophages. J Am Soc Nephrol 6:207-213, 1995
68. AHMED MI, RAWAL PA, PATEL NM, et al: In vitro buffering capacity of residual peritoneal dialysis fluid: Implications for peritoneal dialysis therapy. Artif Organs 16:416-418, 1992
69. MAHIOUT A, BRUNKHORST R: Pyruvate anions neutralize peritoneal dialysate cytotoxicity. Nephrol Dial Transplant 10:391-394, 1995
70. LARKINS RG, DUNLOP ME: The link between hyperglycaemia and diabetic nephropathy. Diabetologia 35:499-504, 1992